• Return to HOME


  • Home
  • Services
    • Clinical & Medical Consulting
    • Business Development
    • Pharmaceutical
    • Regulatory Affairs
    • Legal Consulting
  • Our Team
    • Michael Epstein, MD, FACG, AGAF
  • News
  • Blog
  • Contact


Over-the-counter IBgard improves IBS symptoms

July 24, 2015
by Epstein Associates
Comments are off

WASHINGTON — Michael Epstein, MD, senior medical advisor for IMHealthScience, discusses his presentation on IBgard, a new medical food product for the treatment of diarrhea-predominant and mixed-symptom irritable bowel syndrome. According to a press release, IBgard works by delivering peppermint oil to the lower gut.

Read more here…

Social Share
  • google-share

Key Services

  • Clinical & Medical Consulting
  • Business Development
  • Pharmaceutical
  • Regulatory Affairs
  • Legal Consulting

News & Announcements

Achieving successful bowel preparation with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a Phase 3 trial
Jul 25, 2017
Novel 1L Polyethylene Glycol (PEG)-Based Bowel Preparation NER1006 Achieves High Quality Bowel Cleansing with a Lower Volume than Standard 2L PEG + Ascorbate and Under 3L Total Fluid Volume Intake
Jul 25, 2017
Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial
Jul 25, 2017

410-224-4887 x453

Epstein Associates, LLC
621 Ridgely Avenue, Suite 204
Annapolis, MD 21401

  • Home
  • Services
  • Our Team
  • News
  • Blog
  • Contact

© Copyright 2015, Epstein Associates, LLC
Website Design by Calvert Design Group, Inc.